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Abstract
Background: Delirium is a highly prevalent and morbid syndrome in intensive care units (ICUs). Changing the stressful
environment within the ICU via music may be an effective and a scalable way to reduce the burden of delirium.
Methods/design: The Decreasing Delirium through Music (DDM) study is a three-arm, single-blind, randomized controlled
feasibility trial.
Sixty patients admitted to the ICU with respiratory failure requiring mechanical ventilation will be randomized to one of
three arms (20 participants per arm): (1) personalized music, (2) non-personalized relaxing music, or (3) attention-control.
Music preferences will be obtained from all enrolled participants or their family caregivers. Participants will receive two 1-h
audio sessions a day through noise-cancelling headphones and mp3 players. Our primary aim is to determine the feasibility
of the trial design (recruitment, adherence, participant retention, design and delivery of the music intervention). Our secondary
aim is to estimate the potential effect size of patient-preferred music listening in reducing delirium, as measured by the
Confusion Assessment Method for the ICU (CAM-ICU). Participants will receive twice daily assessments for level of sedation
and presence of delirium. Enrolled participants will be followed in the hospital until death, discharge, or up to 28 days, and
seen in the Critical Care Recovery Clinic at 90 days.
Discussion: DDM is a feasibility trial to provide personalized and non-personalized music interventions for critically ill,
mechanically ventilated patients. Our trial will also estimate the preliminary efficacy of music interventions on reducing
delirium incidence and severity.
Trial registration: ClinicalTrials.gov, Identifier: NCT03095443. Registered on 23 March 2017.
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Background
Delirium is characterized by a disturbance of conscious-
ness, the presence of inattention, disorganized thinking,
and a fluctuating course [1]. It has an incidence as high as
85% in mechanically ventilated patients, and is associated
with longer hospital stays, increased hospital and post-dis-
charge mortality as well as higher healthcare costs [2–6].
Furthermore, over 30% of patients with delirium experience
long-term cognitive impairment [7].
Despite the incidence and morbidity associated with de-
lirium, effective pharmacological and non-pharmacological
interventions to treat this condition are lacking. Music lis-
tening is a unique, non-pharmacological intervention that
may reduce delirium incidence and severity through the
inhibition of inflammation. Prior music listening research
has demonstrated a calming effect with slow-tempo music.
This is hypothesized to be secondary to entrainment of the
autonomic nervous system, reduction in sympathetic acti-
vation and dampening of the inflammatory state [8]. With
various pathophysiological models for delirium implicating
neuro-inflammation, neurotransmitter imbalances and an
aberrant stress reaction, [9] this makes music listening a
promising intervention to prevent or treat delirium.
Music intervention studies in the intensive care unit
(ICU) have focused on its effects on anxiety, pain, toler-
ance of non-invasive ventilation, and physiological indica-
tors of the stress response (heart rate, blood pressure,
catecholamines, cortisol), but, to date, studies on the effect
of music listening on ICU-related delirium have not been
conducted [10–16]. Our study aims to test the feasibility
of music listening, and estimate the potential effect size of
music listening on delirium, in critically ill patients on
mechanical ventilation.
Methods/design
Rationale
We are conducting a feasibility trial to deliver personal-
ized music for critically ill patients based on preferences
supplied by their surrogates or family members. Partici-
pants in the study are unlikely to be able to communicate
or choose their own music due to invasive mechanical
ventilation, the need for high ventilator support, and
hemodynamic instability. Our study design also includes
single blinding and three intervention arms (personalized
music, non-personalized, investigator-selected music, and
attention-control) which adds complexity to the unique
ICU environment.
Our study aims to gather data to help inform a defini-
tive randomized controlled trial.
Outcomes
Our study aims to answer the following question: In
critically ill patients on mechanical ventilation, is the
design and implementation of music listening feasible?
The primary outcomes of our study are: (1) to assess
recruitment rates, described by the number of participants
approached and their rates of consent, (2) to assess adher-
ence to the intervention by number of listening sessions
completed per patient, and (3) to assess retention by the
number of participants completing the study.
The secondary outcome in the study is to estimate the
potential effect size of patient-preferred music in redu-
cing delirium incidence as measured by the Confusion
Assessment Method for the ICU (CAM-ICU).
Design
DDM is a feasibility study with a three-arm, single-blind,
randomized controlled design.
Patients admitted to the ICU with respiratory failure
requiring mechanical ventilation are eligible. Sixty partici-
pants will be randomized to one of three arms (20 patients
per arm): (1) personalized music, (2) non-personalized
relaxing music, or (3) attention-control (see Fig. 1). Partici-
pants will receive two 1-h audio sessions a day through
noise-cancelling headphones (and mp3 players). We chose
an attention-control arm (rather than usual care) to test the
feasibility of a placebo, and to control for the non-specific
effects of headphone and non-audio sounds in the study.
The trial protocol was written according to the Stand-
ard Protocol Items: Recommendations for Interventional
Trials Statement (SPIRIT). A SPIRIT Figure is provided
(see Fig. 2) and a SPIRIT Checklist is included as
Additional file 1.
Setting
Patients admitted to the medical or surgical ICU service
at Sidney and Lois Eskenazi Hospital (Indianapolis, Indi-
ana) are eligible. Eskenazi Hospital is a busy 618-bed,
urban, safety net hospital with 44 ICU beds (22 surgical,
22 medical), averaging 120 ICU admissions per month.
Demographics of this ICU are: mean age of patients
53.7 years, 45% African American, 47% female, 29% age
60 years or older, and 16% with Medicaid insurance.
Participants
The target population for our trial is adults aged 18 years
and older, admitted to the medical or surgical ICU on
invasive mechanical ventilation.
Consent
Individuals deemed eligible for the study will be approached
for consent. If on mechanical ventilation and unable to
consent, the patient’s surrogate or healthcare representative
will be approached for consent.
Inclusion criteria
Inclusion criteria for our study are: (1) age 18 years or
older, (2) English speaking, (3) admitted to the ICU
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(medical or surgical), and (4) receiving mechanical ventila-
tion for an anticipated duration of 24 h or longer, provided
that the patient has not already been on the ventilator
longer than 48 h at the time of enrollment.
Exclusion criteria
Patients are excluded from our study if any of the follow-
ing conditions are present: (1) severe dementia or chronic
neurological disease, with an IQCODE score of 4.5 or
greater; [17–19] (2) acute or subacute severe neurological
deficit or injury; (3) severe psychiatric illness (not includ-
ing depression) or developmental problems; (4) suspected
or confirmed drug or alcohol intoxication/overdose or
withdrawal; (4) uncorrected or severe hearing or vision
impairment; (5) coma after cardiac arrest and/or
hypothermia protocol; (6) pregnant or nursing women; (7)
prisoners; (8) expected death within 24 h of enrollment or
lack of commitment to aggressive treatment by family or
the medical team; (9) inability to obtain consent from
legally authorized representative within 72 h of meeting
eligibility; and (10) attending physician or healthcare
team refusal.
Materials
Participants are provided with noise-cancelling head-
phones (Maxell NC-IV Superior Noise Cancellation),
with mp3 player devices (Apple iPod Shuffle 2GB, 6th
generation or Goldenseller 16GB Mp3 Player) during
the trial. Music tracks and audiobooks were purchased
from Apple Music Store (iTunes).
Study procedures
Screening
Patients admitted to the ICU are screened on a daily basis.
Music preference data will be collected from all enrolled
Screening
ICU Patients on Mechanical Ventilation
Allocation 
n = 60
Personalized Music
n = 20
Attention-Control
n = 20
Blinded Initial Assessments 
(Music preferences, IQCODE, Katz, Lawton, RASS, CAM-ICU, CPOT, clinical and laboratory data)
Enrollment
Non-Personalized Music
n = 20
Blinded Assessments Until Hospital Discharge or 28 days 
(RASS, CAM-ICU, CPOT, VASA, safety monitoring)
Twice Daily
Blinded Assessments 
(Richard-Campbell Questionnaire, RASS, CAM-ICU)
Discharge
Music Intervention
Two 60-min sessions up to 7 days
Critical Care Recovery Center Follow Up90 Days
Fig. 1 DDM study flowchart, interventions, and assessments. Abbreviations: CAM-ICU Confusion Assessment Method for the Intensive Care Unit,
CPOT Critical Pain Observation Tool, Katz Katz Index of Independence in Activities of Daily Living, Lawton Lawton Instrumental Activities of Daily
Living, RASS Richmond Agitation-Sedation Scale, VASA Visual Analog Scale for Anxiety
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participants (through their surrogates) regardless of inter-
vention arm.
Participant randomization
Using a computer-generated list of random numbers cre-
ated by study statistician, participants are randomized by
permuted block with varying block sizes. Randomization
occurs within 48 h of enrollment in a 1:1:1 ratio, and only
the unblinded study coordinator, who also programs the
music devices, is aware of the randomization assignment.
Study duration/termination
The music intervention period is 7 days post
randomization. Participants will stop receiving music
sessions early if they choose to withdraw, are trans-
ferred out of the ICU, die, or are discharged. In-
hospital follow-up continues to 28 days or until dis-
charge, whichever occurs earlier, by daily assessment,
unless they choose to withdraw. All participants will
be invited for follow-up in the Critical Care Recovery
Clinic at 90 days.
Pre-intervention phase
Upon enrollment, demographics, clinical data (vital signs,
pertinent laboratory and imaging data), severity of illness
(APACHE II and SOFA), comorbidity burden (Charlson
Comorbidity Index), pertinent home medications, reason
for admission, pre-hospital functional status (Katz and Law-
ton), and cognitive function (Informant Questionnaire on
Cognitive Decline in the Elderly (IQCODE)) are obtained
[20–23]. Cumulative doses of antipsychotic, analgesic, seda-
tive, and anxiolytic medications are also recorded.
A previously described music-preference assessment
tool is utilized to obtain the participants’ music prefer-
ences from family members/surrogates [24]. We collect
information about genre likes and dislikes, as well as
specific favorite artists, tracks, and instruments.
Fig. 2 Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) Figure for the DDM Trial. Abbreviations: CAM-ICU Confusion
Assessment Method for the Intensive Care Unit, CPOT Critical Pain Observation Tool, ICU intensive care unit, IQCODE Informant Questionnaire on
Cognitive Decline in the Elderly, RASS Richmond Agitation-Sedation Scale
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A pre-intervention level of consciousness and delirium
assessment is performed upon enrollment through the
Richmond Agitation Sedation Scale and the CAM-ICU,
respectively [3, 25].
Playlist development
Following enrollment consent, blinded research personnel
enter the participant’s music preferences into a Research
Electronic Data Capture (REDCap) database. The unblinded
study coordinator programs music devices based on an indi-
vidual study participant’s randomization status. For those
randomized to personalized music, Apple Music is utilized
to create a playlist based on their musical interests.
Participants randomized to non-personalized music
received an mp3 player programmed with slow-tempo,
relaxing music and instrumental sounds (piano, relaxing
rainfall sounds, and classical music). Finally, participants
randomized to attention-control receive a device with
audiobooks. The audiobooks include Treasure Island,
Harry Potter, and Dr. Seuss’ Oh the Places You’ll Go!, and
were chosen for their readability and for their broad appeal.
The playlist for each participant is carefully tracked,
which will permit subsequent analysis should particular
books or tracks be associated with increased delirium
incidence or severity.
To avoid unblinding study personnel to the interven-
tion arm, the coordinator waits a minimum of 4 h to
release the mp3 device for use in the study. Prior to allo-
cating devices to patient rooms, all devices are checked
to ensure that identifying data including name, artist,
collection, and genre have been removed, the device is
clean and in good functioning order, and volume is set
to a pre-specified level.
Intervention phase
Music listening sessions are twice a day, for 1 h at a
time, from 10:00 to 11:00 and 14:00 to 15:00, for 7 days.
The times are based on feedback from ICU nurses asso-
ciated with least interference with clinical activities.
Music listening is provided for 7 days unless the partici-
pant refuses, withdraws, is transferred out of the ICU, or
dies. Participants extubated within the 7-day period con-
tinue to receive the intervention unless they are trans-
ferred out of the ICU. Participants remaining in the ICU
after 7 days will not receive further intervention due to
the resource limitations of our feasibility study.
During listening sessions, a conducive listening envir-
onment is created; medical teams are asked to avoid
non-urgent patient care activities, the in-room television
is turned off, family members are asked to limit their in-
teractions with the patient, and the door is closed to
limit outside noise. As all three arms of the trial will
receive a conducive listening environment, and due to
the use of noise-cancelling headphones in these
settings, we believe that the audio dose will remain as
the pure active intervention.
Participants receive their first dose of music listening, in
one of these windows, as soon after enrollment as possible.
The ICU clinical nurses receive on-site training in the
study protocol, and in the operation of the music devices
and headphones. Blinded research personnel and/or hos-
pital nurses start the music sessions by placing the head-
phones on the participants and activating the audio.
Adherence is monitored by recording the start and stop
date and times for each session. The participant’s heart rate
and blood pressure pre and post session are also recorded.
All participants in the trial receive the ABCDEF bun-
dle that is standard of care in the ICU where the study
is being conducted. The ABCDEF bundled delirium care
protocol places a multidisciplinary focus on daily ventilator
liberation trials, sedation vacation, choice and optimization
of sedation, nursing-led delirium screenings, early mobility,
and family/social support [26]. Participants in the study
will continue to have physician-determined sedation with-
out input on choice of sedation from our trial.
Blinding during intervention
We are using various measures to ensure concealment
of a participant’s allocation. Only the unblinded study
coordinator programs the audio devices, and ensures
that the tracks are anonymized (renamed to a series of
digits or letters), to prevent unblinding when bedside
staff view the audio device’s screen. Our protocol also
benefits from the fact that the majority of audio devices
lack screens entirely (Apple iPod Shuffle). Participants,
their family members/surrogates, and hospital nurses are
asked not to share a patient’s randomization with anyone
in the study, should they become aware of it. Audio is
not turned on until the headphones are securely placed
on the participant to prevent study personnel from inad-
vertently hearing the output. Participants are permitted
to change tracks or adjust the volume if needed. Should
one of the study personnel become unblinded, they are
reassigned to other study participants. To assess the fi-
delity of these efforts, we will survey research personnel
to predict patient randomization in a subset of
participants.
Assessments during intervention
All assessments are performed by blinded research assis-
tants. Assessments occur twice a day, approximately at
11:00 and 15:00 (after audio interventions). Study personnel
perform the following: (1) Richmond Agitation-Sedation
Scale (RASS) to document level of consciousness; (2)
Confusion Assessment Method for the ICU (CAM-ICU)
to screen for delirium [3, 25, 27], and CAM-ICU-7 to
determine delirium severity [28]; (3) Critical Care Pain
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Observation Tool (CPOT) to determine level of analgesia
and symptom control [29]; (4) Faces Anxiety Scale (per-
formed after the morning listening session) [30, 31]; (5)
physical therapy and occupational therapy notes are evalu-
ated and each participant’s mobility milestones are
recorded using Hodgson Mobility Scale [32]; and (6)
adverse events are assessed (including seizures while listen-
ing, localized skin breakdown or cellulitis around the ears)
and are reported to the Institutional Review Board (IRB)
per usual protocol.
Post intervention
Participants receive in-hospital assessments by blinded
research personnel until hospital discharge, day 28, or they
withdraw or die. Twice a day, at approximately 11:00 and
15:00, study personnel perform the RASS, CAM-ICU,
CAM-ICU-7, CPOT, and the Faces Anxiety Scale, evaluate
mobility with the Hogdson Mobility Scale, and record
adverse events.
Beginning within 72 h of extubation or removal of
the endotracheal tube, and if the patient is CAM-ICU
negative, the participant is reconsented for the study.
The participant is also screened for obstructive sleep
apnea with STOP-BANG and the Richards-Campbell
Sleep Questionnaires, given the higher incidence of
delirium in patients with sleep apnea and disturbed
sleep quality [33–35].
Follow-up
Participants are invited to follow-up in the Critical Care
Recovery Center (CCRC) at 90 days from hospital dis-
charge. The CCRC is an outpatient interdisciplinary
clinic comprising care coordinators (social worker,
nurse), a critical care physician, psychometrician, and
psychologist. Its goal is to maximize the cognitive, phys-
ical, and psychological recovery of ICU survivors
through comprehensive assessments and personalized
recovery plans incorporating self-management protocols.
Data collection
Prior to the trial initiation, study personnel underwent
training sessions on data collection and were individually
tested on data entry as well as outcome assessments.
Study data have been collected and managed using
REDCap electronic data capture tools hosted at Indi-
ana University. REDCap is a secure, web-based appli-
cation designed to support data capture for research
studies, providing: (1) an intuitive interface for vali-
dated data entry; (2) audit trails for tracking data ma-
nipulation and export procedures; (3) automated
export procedures for seamless data downloads to
common statistical packages; and (4) procedures for
importing data from external sources.
On a daily basis during all phases of the study and for
up to 28 days, blinded personnel collect vital signs, per-
tinent laboratory and imaging data, data to calculate
severity of illness, clinical events including surgery and
tracheostomy, duration and modes of mechanical venti-
lation, cumulative daily doses of sedatives, analgesics,
antipsychotics, presence of shock requiring vasopressors,
and the administration of systemic steroids or paralytic
agents. We also collect disposition at discharge.
Sample size and feasibility
We determined criteria for feasible recruitment rates
based on prior research. A large trial of music in the
ICU had a recruitment rate of 33%, while delirium stud-
ies have had recruitment rates close to 30% [11]. Our
own recruitment experience at the institution where this
trial is being conducted suggests recruitment rates near
60%. Given a sample size of 60 participants, we will be
able estimate a recruitment rate of 60% to within a 95%
confidence interval of ± 12.40%. A recruitment rate of
48% would be lower than our institutional norm, but
remains higher than other similar trials.
Adherence to the intervention will be defined as the
percentage of audio sessions completed per patient (a
maximum of 14 sessions per patient at a rate of two ses-
sions per day for 7 days), adjusted for number of eligible
sessions based on length of stay in the ICU. Our sample
size of 60 participants will permit an estimate of the ad-
herence rate of 80% to within a 95% confidence interval
of ± 10.12%. We determined a retention rate of 80% for
feasibility, defined by the percentage of participants
completing all in-hospital components of the study,
which can be estimated with a similar confidence inter-
val. As a pilot study, we anticipate that a sample size of
60 participants will be sufficient to determine feasibility.
Our pilot study will help calculate sample size needed
for a definitive randomized controlled trial. A decrease
of 15% in delirium incidence between groups would
make a larger trial feasible, with a three-arm trial requir-
ing 548 participants (allowing 20% for attrition, α = 0.05,
power = 80%).
Statistical analysis
We will use chi-square tests to determine if study re-
tention rates differ across the three groups. Adher-
ence will be defined as the percentage of audio
sessions completed per patient, adjusted for number
of eligible sessions based on length of stay in the
ICU. Depending on the distribution of this outcome,
we will use either analysis of variance (ANOVA) (for
normally distributed data) or the Kruskal-Wallis test
(non-normal data) to determine if adherence differs
between the three study arms.
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Discussion
DDM is a feasibility trial for providing personalized and
non-personalized music interventions for critically ill,
mechanically ventilated patients. In our trial we also
estimate the preliminary efficacy of music interventions
on reducing delirium incidence and severity.
Our protocol builds on prior research as the anxiolytic
properties of music have been well documented [12].
Music interventions for hospitalized and non-hospitalized
patients have shown decreases in heart rate and blood
pressure, and were hypothesized to be a consequence of a
lower sympathetic drive [12, 14]. Earlier studies have also
shown lower sedative doses for patients undergoing pro-
cedures and utilizing preferred music listening [11]. Prior
studies have been limited by methodological challenges,
including small sample size, lack of blinding, and exclu-
sion of the critically ill. The strengths of our protocol
include blinding of outcome assessors, twice daily delir-
ium assessments, as well as assessments of pain, anxiety,
and mobility milestones. Furthermore, our study benefits
from high external validity through inclusion of the ICU’s
sickest patients.
Music listening has been shown to activate areas of
the brain involved with memory, cognitive function, and
emotion [36, 37]. By reducing brain dysfunction and
increasing activity in the areas related to memory, music
could help retain cognitive function, particularly in older
people who experience critical illness or injury. Extended
applications of our study could permit comparison of
neurocognitive outcomes between music and attention-
control arms in future studies.
As a feasibility study, our protocol will enable us to
perform hypothesis testing, develop music algorithms,
and implement a music intervention protocol in a busy
ICU. The results of this study will inform the protocol
design of a larger study.
Trial status
Enrollment is ongoing. Recruitment began in December
2016 and is expected to conclude in January 2018.
Target enrollment for the study is 60 participants. The
trial was retroactively registered at ClinicalTrials.gov.
Additional file
Additional file 1: SPIRIT 2013 Checklist: recommended items to address
in a clinical trial protocol and related documents. (DOC 122 kb)
Abbreviations
CAM-ICU: Confusion Assessment Method for the Intensive Care Unit;
DDM: Decreasing Delirium through Music; IQCODE: Information
Questionnaire on Cognitive Decline in the Elderly
Acknowledgements
We would like to thank Emily Behrens, the Regenstrief research team and
Eskenazi Hospital for their efforts in development of this protocol.
Funding
The DDM Trial is supported by Regenstrief Institute’s Innovations Grant.
Regenstrief Institute did not participate in the design of this study. SK is
supported by NHLBI 5T32HL091816-07.
Availability of data and materials
Data results from this feasibility study are unavailable at the time of publication.
Access to the final dataset will be retained with the study investigators.
Compensation for the trial, including harm, is not intended. Results of the trial are
intended for publication in a peer-reviewed journal, by the authors, and assistance
of professional writers is not expected. Results will be shared with participants of
the study by e-mail, and within our hospital system. Full access to the protocol or
participant-level dataset is available upon request.
Authors’ contributions
Study concept and design: BK. Data acquisition: SK, SM, and AH. Data
analysis: AP. Drafting of manuscript: SK. Critical revision of the manuscript:
SW, MB, AH, LC, WT, and BK. Statistical analysis: AP. Obtained funding: BK.
Administrative support: AH. Study supervision: BK. All authors read and
approved the final manuscript.
Ethics approval and consent to participate
The DDM Trial received Indiana University’s Institutional Review Board
approval (IRB 1608887741A003).
For participants deemed eligible for enrollment, the patient and/or their
legal representative are approached for consent.
Consent for publication
Consent forms for the trial include consent for publication of results in peer-
reviewed journals.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Division of Pulmonary, Critical Care, Sleep and Occupational Medicine,
Department of Medicine, Indiana University School of Medicine, Indianapolis,
IN, USA. 2Department of Psychiatry, Indiana University School of Medicine,
Indianapolis, IN, USA. 3Indiana University Center of Health Innovation and
Implementation Science, Indianapolis, IN, USA. 4IU Center of Aging Research,
Regenstrief Institute, Indianapolis, IN, USA. 5Music Therapy Department,
Augsburg College, Minneapolis, MN, USA. 6Department of Nursing, Nursing
Research Division, Mayo Clinic, Rochester, MN, USA. 7Indiana Clinical and
Translational Research Institute, Indiana University School of Medicine,
Indianapolis, IN, USA. 8Department of Biostatistics, Indiana University School
of Medicine, Indianapolis, IN, USA. 9Sandra Eskenazi Center for Brain Care
Innovation, Eskenazi Hospital, Indianapolis, IN, USA. 10Division of Geriatrics
and General Internal Medicine, Department of Internal Medicine, Indiana
University School of Medicine, Indianapolis, IN, USA.
Received: 9 May 2017 Accepted: 14 November 2017
References
1. Miller RR, Ely EW, editors. Delirium and cognitive dysfunction in the
intensive care unit. Seminars in respiratory and critical care medicine.
New York: Thieme; 2006.
2. Ely E, Inouye SK, Bernard GR, et al. Delirium in mechanically
ventilated patients: validity and reliability of the confusion
assessment method for the intensive care unit (cam-icu). JAMA.
2001;286(21):2703–10.
3. Ely EW, Margolin R, Francis J, May L, Truman B, Dittus R, et al.
Evaluation of delirium in critically ill patients: validation of the
Confusion Assessment Method for the Intensive Care Unit (CAM-ICU).
Crit Care Med. 2001;29(7):1370–9.
Khan et al. Trials  (2017) 18:574 Page 7 of 8
4. McNicoll L, Pisani MA, Zhang Y, Ely EW, Siegel MD, Inouye SK. Delirium in
the intensive care unit: occurrence and clinical course in older patients.
J Am Geriatr Soc. 2003;51(5):591–8.
5. Thomason JW, Shintani A, Peterson JF, Pun BT, Jackson JC, Ely EW. Intensive
care unit delirium is an independent predictor of longer hospital stay:
a prospective analysis of 261 non-ventilated patients. Crit Care. 2005;9(4):R375.
6. Ely E, Shintani A, Truman B, et al. Delirium as a predictor of mortality in
mechanically ventilated patients in the intensive care unit. JAMA.
2004;291(14):1753–62.
7. Jackson JC, Hart RP, Gordon SM, Shintani A, Truman B, May L, et al. Six-
month neuropsychological outcome of medical intensive care unit patients.
Crit Care Med. 2003;31(4):1226–34.
8. Beaulieu-Boire G, Bourque S, Chagnon F, Chouinard L, Gallo-Payet N, Lesur
O. Music and biological stress dampening in mechanically-ventilated
patients at the intensive care unit ward—a prospective interventional
randomized crossover trial. J Crit Care. 2013;28(4):442–50.
9. Khan BA, Farber MO, Campbell N, Perkins A, Prasad NK, Hui SL, et al. S100
calcium binding protein B as a biomarker of delirium duration in the
intensive care unit—an exploratory analysis. Int J Gen Med. 2013;6:855–61.
10. Chlan L. Effectiveness of a music therapy intervention on relaxation
and anxiety for patients receiving ventilatory assistance. Heart Lung.
1998;27(3):169–76.
11. Chlan LL, Weinert CR, Heiderscheit A, Tracy MF, Skaar DJ, Guttormson JL, et
al. Effects of patient-directed music intervention on anxiety and sedative
exposure in critically ill patients receiving mechanical ventilatory support:
a randomized clinical trial. JAMA. 2013;309(22):2335–44.
12. Han L, Li JP, Sit JW, Chung L, Jiao ZY, Ma WG. Effects of music intervention
on physiological stress response and anxiety level of mechanically
ventilated patients in China: a randomised controlled trial. J Clin Nurs.
2010;19(7-8):978–87.
13. Hetland B, Lindquist R, Chlan LL. The influence of music during mechanical
ventilation and weaning from mechanical ventilation: a review. Heart Lung.
2015;44(5):416–25.
14. Korhan EA, Khorshid L, Uyar M. The effect of music therapy on physiological
signs of anxiety in patients receiving mechanical ventilatory support.
J Clin Nurs. 2011;20(7-8):1026–34.
15. Lee CH, Lee CY, Hsu MY, Lai CL, Sung YH, Lin CY, et al. Effects of music
intervention on state anxiety and physiological indices in patients
undergoing mechanical ventilation in the intensive care unit. Biol Res Nurs.
2017;19(2):137–44.
16. Mofredj A, Alaya S, Tassaioust K, Bahloul H, Mrabet A. Music therapy, a
review of the potential therapeutic benefits for the critically ill. J Crit Care.
2016;35:195–9.
17. Jorm AF. A short form of the Informant Questionnaire on Cognitive Decline
in the Elderly (IQCODE): development and cross-validation. Psychol Med.
1994;24(1):145–53.
18. Jorm AF, Jacomb PA. The Informant Questionnaire on Cognitive Decline in
the Elderly (IQCODE): socio-demographic correlates, reliability, validity and
some norms. Psychol Med. 1989;19(4):1015–22.
19. Jorm AF, Scott R, Cullen JS, MacKinnon AJ. Performance of the Informant
Questionnaire on Cognitive Decline in the Elderly (IQCODE) as a screening
test for dementia. Psychol Med. 1991;21(3):785–90.
20. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying
prognostic comorbidity in longitudinal studies: development and validation.
J Chronic Dis. 1987;40(5):373–83.
21. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. Studies of illness in
the aged: The index of ADL: a standardized measure of biological and
psychosocial function. JAMA. 1963;185(12):914–9.
22. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of
disease classification system. Crit Care Med. 1985;13(10):818–29.
23. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, et al.
The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ
dysfunction/failure. On behalf of the Working Group on Sepsis-Related
Problems of the European Society of Intensive Care Medicine. Intensive
Care Med. 1996;22(7):707–10.
24. Chlan L, Heiderscheit A. A tool for music preference assessment in critically
ill patients receiving mechanical ventilatory support. Music Ther Perspect.
2009;27(1):42–7.
25. Sessler CN, Gosnell MS, Grap MJ, Brophy GM, O’Neal PV, Keane KA, et al. The
Richmond Agitation-Sedation Scale: validity and reliability in adult intensive
care unit patients. Am J Respir Crit Care Med. 2002;166(10):1338–44.
26. Marra A, Ely EW, Pandharipande PP, Patel MB. The ABCDEF Bundle in critical
care. Crit Care Clin. 2017;33(2):225–43.
27. Khan BA, Guzman O, Campbell NL, Walroth T, Tricker J, Hui SL, et al.
Comparison and agreement between the Richmond Agitation-Sedation
Scale and the Riker Sedation-Agitation Scale in evaluating patients’ eligibility
for delirium assessment in the ICU. Chest. 2012;142(1):48–54.
28. Khan BA, Perkins AJ, Gao S, Hui SL, Campbell NL, Farber MO, et al. The
Confusion Assessment Method for the ICU-7 Delirium Severity Scale:
a novel delirium severity instrument for use in the ICU. Crit Care Med.
2017;45(5):851–7.
29. Gelinas C, Fortier M, Viens C, Fillion L, Puntillo K. Pain assessment and
management in critically ill intubated patients: a retrospective study.
Am J Crit Care. 2004;13(2):126–35.
30. Gustad LT, Chaboyer W, Wallis M. Performance of the faces anxiety scale in
patients transferred from the ICU. Intensive Crit Care Nurs. 2005;21(6):355–
60. Epub 2005 Aug 15.
31. McKinley S, Stein-Parbury J, Chehelnabi A, Lovas J. Assessment of anxiety in
intensive care patients by using the Faces Anxiety Scale. Am J Crit Care.
2004;13(2):146–52.
32. Hodgson C, Needham D, Haines K, Bailey M, Ward A, Harrold M, et al.
Feasibility and inter-rater reliability of the ICU Mobility Scale. Heart Lung.
2014;43(1):19–24.
33. Chung F, Yegneswaran B, Liao P, Chung SA, Vairavanathan S, Islam S, et al.
STOP questionnaire: a tool to screen patients for obstructive sleep apnea.
Anesthesiology. 2008;108(5):812–21.
34. Kamdar BB, Shah PA, King LM, Kho ME, Zhou X, Colantuoni E, et al. Patient-
Nurse Interrater Reliability and Agreement of the Richards-Campbell Sleep
Questionnaire. Am J Crit Care. 2012;21(4):261–9.
35. Mirrakhimov AE, Brewbaker CL, Krystal AD, Kwatra MM. Obstructive sleep
apnea and delirium: exploring possible mechanisms. Sleep Breath.
2014;18(1):19–29.
36. Stubbs T. Experiences and perceptions of music therapy in critical illness.
Nurs Times. 2005;101(45):34–6.
37. Zhang Y, Cai J, An L, Hui F, Ren T, Ma H, et al. Does music therapy enhance
behavioral and cognitive function in elderly dementia patients?
A systematic review and meta-analysis. Ageing Res Rev. 2017;35:1–11.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Khan et al. Trials  (2017) 18:574 Page 8 of 8
